Clinical Trial Update: Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular Degeneration [EARLY_Phase 1]

View source ↗

Summary

An early-phase pilot study evaluated Lucentis (ranibizumab) in combination with proton beam irradiation for wet age-related macular degeneration. The study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: University of California, Davis | Conditions: Age-related Macular Degeneration | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2016-07-11